BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8872149)

  • 1. Thrombomodulin as a marker of vascular and lymphatic tumours.
    Appleton MA; Attanoos RL; Jasani B
    Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
    Suster S; Wong TY
    Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
    Manning T; Smoller BR; Horn TD; El Darouti M; Marzouk S; Hadidi HE; Ramadan S
    J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections.
    Ramani P; Bradley NJ; Fletcher CD
    Histopathology; 1990 Sep; 17(3):237-42. PubMed ID: 2242851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
    Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
    J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spindle cell haemangioendothelioma--an acquired vascular lesion of uncertain nature.
    Kumarasinghe MP; Bian NS; Hai LB
    Ceylon Med J; 1999 Jun; 44(2):89-91. PubMed ID: 10565076
    [No Abstract]   [Full Text] [Related]  

  • 7. Sphingosine-1-phosphate receptor 1 is a useful adjunct for distinguishing vascular neoplasms from morphological mimics.
    Akiyama T; Hamazaki S; Monobe Y; Nishimura H; Irei I; Sadahira Y
    Virchows Arch; 2009 Feb; 454(2):217-22. PubMed ID: 19005676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
    Miettinen M; Lindenmayer AE; Chaubal A
    Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant vascular tumors of the liver: radiologic-pathologic correlation.
    Buetow PC; Buck JL; Ros PR; Goodman ZD
    Radiographics; 1994 Jan; 14(1):153-66; quiz 167-8. PubMed ID: 8128048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining for CD31 and CD34 in Kaposi sarcoma.
    Russell Jones R; Orchard G; Zelger B; Wilson Jones E
    J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ; Bailey D; Marks A
    Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of ERG, Fli-1, CD34, CD31 and Fâ…§RAg expression in hepatic malignant vascular tumors].
    Wang ZB; An XJ; Deng JF; Liu JH; Shi HY
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):760-763. PubMed ID: 29136688
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics.
    Folpe AL; Chand EM; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular tumors.
    Walsh JJ; Eady JL
    Hand Clin; 2004 Aug; 20(3):261-8, v-vi. PubMed ID: 15275685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
    Poblet E; Gonzalez-Palacios F; Jimenez FJ
    Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Vascular Tumors.
    Goss JA; Greene AK
    Otolaryngol Clin North Am; 2018 Feb; 51(1):89-97. PubMed ID: 29217070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular tumors and pseudotumors. Pyogenic granuloma (lobular capillary hemangioma)].
    Baglin AC
    Ann Pathol; 2011 Aug; 31(4):266-70. PubMed ID: 21839350
    [No Abstract]   [Full Text] [Related]  

  • 20. Recently characterized vascular tumours of skin and soft tissues.
    Tsang WY; Chan JK; Fletcher CD
    Histopathology; 1991 Dec; 19(6):489-501. PubMed ID: 1786935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.